I'm not that keen to see a name change, I think the market will get over the stigma of Esragate when Phosphagenics starts to deliver deals that clearly demonstrate our Company is making more money than it spends.
I particularly don't like Alyptus...if we are resigned to going down a name change path then surely there must be a better choice than that.
Off the top of my head I can think of two that speak to what we do and the ASX codes doesn't appear to be taken.
Breakthough Medical Delivery (BMD)
Enhanced Drug Delivery (EDD)
Why I will vote NO to Alyptus as the new company name, page-17
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $7.26K | 2.420M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 36997351 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 38391286 | 28 |
View Market Depth
| Last trade - 15.28pm 11/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |